Daniel S. Childs

979 total citations · 1 hit paper
61 papers, 496 citations indexed

About

Daniel S. Childs is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Daniel S. Childs has authored 61 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 30 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Oncology. Recurrent topics in Daniel S. Childs's work include Prostate Cancer Treatment and Research (30 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cancer Treatment and Pharmacology (9 papers). Daniel S. Childs is often cited by papers focused on Prostate Cancer Treatment and Research (30 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cancer Treatment and Pharmacology (9 papers). Daniel S. Childs collaborates with scholars based in United States, United Kingdom and Pakistan. Daniel S. Childs's co-authors include Aminah Jatoi, J. David Sweatt, Mikael C. Guzman-Karlsson, Jeremy J. Day, Jacob J. Orme, Danny G. Winder, Gregg D. Stanwood, Christopher M. Olsen, A. Tuba Kendi and Geoffrey B. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Daniel S. Childs

42 papers receiving 483 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Theranostics and artificial intelligence: new frontiers in personalized medicine

2024 52 citations Gokce Belge Bilgin, Brian J. Burkett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel S. Childs United States	10	161	122	103	68	66	61	496
Michael Silver United States	15	116 0.7×	122 1.0×	59 0.6×	34 0.5×	67 1.0×	22	598
Xiang Cai China	12	139 0.9×	119 1.0×	74 0.7×	15 0.2×	56 0.8×	22	546
Imma Hernán Spain	16	386 2.4×	78 0.6×	64 0.6×	53 0.8×	95 1.4×	31	712
Yijun Bao China	17	336 2.1×	45 0.4×	75 0.7×	33 0.5×	33 0.5×	40	726
Shan Yao China	15	116 0.7×	54 0.4×	39 0.4×	126 1.9×	22 0.3×	48	630
Márcia Silveira Graudenz Brazil	16	198 1.2×	49 0.4×	169 1.6×	47 0.7×	120 1.8×	52	699
Jun Matsushima Japan	15	148 0.9×	161 1.3×	53 0.5×	49 0.7×	35 0.5×	41	493
Junkai Wang China	13	224 1.4×	134 1.1×	99 1.0×	46 0.7×	21 0.3×	37	644
Susana Hernández Spain	10	138 0.9×	111 0.9×	111 1.1×	14 0.2×	36 0.5×	20	754
Janice A. Zawaski United States	12	93 0.6×	121 1.0×	27 0.3×	94 1.4×	19 0.3×	22	470

Countries citing papers authored by Daniel S. Childs

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Childs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Childs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Childs more than expected).

Fields of papers citing papers by Daniel S. Childs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Childs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Childs. The network helps show where Daniel S. Childs may publish in the future.

Co-authorship network of co-authors of Daniel S. Childs

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Childs. A scholar is included among the top collaborators of Daniel S. Childs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Childs. Daniel S. Childs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Wanling, John F. Gallagher, Andrew F. Voter, et al.. (2025). Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer. Cancers. 17(12). 1960–1960. 1 indexed citations

Jatoi, Aminah, Kathryn J. Ruddy, Jacob J. Orme, et al.. (2025). Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors. Journal of Pain and Symptom Management. 70(2). 182–188.

Naqvi, Syed Arsalan Ahmed, Jack R. Andrews, Alan H. Bryce, et al.. (2025). Automated risk stratification in localized prostate cancer using an AI-assisted framework.. Journal of Clinical Oncology. 43(5_suppl). 341–341.

Andrews, Jack R., Aurélie De Bruycker, Ryan Phillips, et al.. (2025). PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clinical Cancer Research. 31(6). 1142–1149. 5 indexed citations

Bilgin, Gokce Belge, Fabrice Lucien, Aadel A. Chaudhuri, et al.. (2025). Current and future directions in theranostics for neuroendocrine prostate cancer. Cancer Treatment Reviews. 136. 102941–102941. 4 indexed citations

Childs, Daniel S., et al.. (2024). EARLY ADVERSE EVENTS, EMERGENCY ROOM VISITS AND HOSPITALIZATIONS AFTER PSMA BASED RLT: A RETROSPECTIVE ANALYSIS FROM REAL WORLD THERANOSTICS PRACTICE. Urologic Oncology Seminars and Original Investigations. 42. S12–S12.

Ahmed, Mohamed E., Ahmed Mahmoud, Irbaz Bin Riaz, et al.. (2024). Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?. European Urology Open Science. 66. 38–45. 3 indexed citations

Bilgin, Gokce Belge, Brian J. Burkett, Cem Bilgin, et al.. (2024). Neurologic Symptoms After¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience. Journal of Nuclear Medicine. 65(9). 1402–1408.

Mahmoud, Ahmed, Mohamed E. Ahmed, Spyridon P. Basourakos, et al.. (2024). Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Cancers. 16(11). 2080–2080. 2 indexed citations

10.

Mahmoud, Ahmed, Mohamed E. Ahmed, A. Tuba Kendi, et al.. (2023). Low PSA radiographic disease progression on C11‐choline PET. SHILAP Revista de lepidopterología. 5(2). 319–324. 1 indexed citations

11.

Mahmoud, Ahmed, Robert W. Gao, Mohamed E. Ahmed, et al.. (2023). Metastasis-Directed Therapy for Metachronous Lung Metastases in Prostate Cancer. JU Open Plus. 1(10). 2 indexed citations

12.

Mahmoud, Ahmed, Daniel S. Childs, Mohamed E. Ahmed, et al.. (2023). Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis. The Prostate. 84(3). 237–244. 2 indexed citations

13.

Ahmed, Mohamed E., Ahmed Mahmoud, Raevti Bole, et al.. (2023). Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 27(2). 334–338. 1 indexed citations

14.

Childs, Daniel S., Eugene D. Kwon, Mohamed E. Ahmed, et al.. (2023). Characterizing changes in tumor mutational burden (TMB) by serial circulating tumor DNA (ctDNA) testing in patients with advanced prostate cancer (aPC).. Journal of Clinical Oncology. 41(6_suppl). 239–239.

15.

Novotny, Paul J., Elizabeth Cathcart-Rake, Jacob J. Orme, et al.. (2023). An evaluation of the effect of lithium on taxane-induced neuropathy. Supportive Care in Cancer. 31(5). 299–299. 2 indexed citations

16.

Childs, Daniel S., Lindsey R. Sangaralingham, Jacob J. Orme, et al.. (2022). Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy. JCO Oncology Practice. 18(12). e1953–e1960. 3 indexed citations

17.

Childs, Daniel S., et al.. (2020). Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Supportive Care in Cancer. 29(2). 733–739. 3 indexed citations

18.

Bartlett, David J., Daniel S. Childs, Carmen Radecki Breitkopf, et al.. (2018). Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer. American Journal of Hospice and Palliative Medicine®. 35(11). 1384–1389. 2 indexed citations

19.

Childs, Daniel S., et al.. (2018). What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study. Supportive Care in Cancer. 27(1). 249–255. 11 indexed citations

20.

Aseem, Sayed Obaidullah, Daniel S. Childs, & Conor G. Loftus. (2017). Diffuse Small Intestine Erosions and Ulcers in an Immunocompromised Host. Gastroenterology. 154(5). 1241–1243. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact